Most recent technology transfer projects

Funding authority





Development of an enzyme replacement therapy for the treatment of transglutaminase-1-deficient autosomal recessive congenital ichthyosis (FMP, Margitta Dathe and WWU, Heiko Traupe)


Federal Ministry of Education and Research (BMBF)

Targetvalidierung für die pharmazeutische Wirkstoffentwicklung

Evaluating Ena/VASP as a novel relevant drug target for treatment of cancer metastasis (FMP, Ronald Kühne and University of Cologne, Hans-Günther Schmalz)

01.2018 - 04.2020

Bavarian Ministry of Economic Affairs and Media, Energy and Technology

m4 Award

Development of a Tubulis Technologies proprietary ADC for Acute Myeloid Leukemia treatment (Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt/LMU and Christian Hackenberger/FMP)

01.2018 - 12.2019

Federal Ministry for Economic Affairs and Energy (BMWi)

EXIST Forschungstransfer I

Tubulis Technologies, a pre-start-up project affiliated with the Ludwig Maximilians University Munich (LMU, Jonas Helma-Smets, Dominik Schumacher, Heinrich Leonhardt) and the FMP (Christian Hackenberger)

04.2017 - 09.2019

The Michael J. Fox Foundation

Improved Biomarkers & Clinical Outcome Measures - Spring 2016 Program

Supramolecular hosts as combined protein aggregation inhibitors and hyperpolarized MRI reporters, Leif Schröder

09.2016 - 03.2019

Human Frontier Science Program (HFSP)

Program Grant

Imaging cellular function noninvasively with genetically engineered reporters for hyperpolarized MRI, Leif Schröder, FMP & Mikhail Shapiro, Caltech, USA

05.2016 - 04.2019

Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP)
Campus Berlin-Buch
Robert-Roessle-Str. 10
13125 Berlin, Germany
+4930 94793 - 100 
+4930 94793 - 109 (Fax)

Like many sites, we use cookies to optimize the user's browsing experience. Data Protection OK